2080 Century Park E #803 Los Angeles, CA 90067
M-F, 8:30 AM to 5:00 PM

BGB-11417-301
The main objective of this study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia (CLL)

    CONTACT US NOW





    Discover New Possibilities: Find Your Path to Healing through Valkyrie Clinical Trials
    Skip to content